NDC 45802-923-49 - Mesalamine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 45802-923
- Requested NDC
- 45802-923-49
- Package NDCs from labels
- 45802-923-41, 45802-923-49
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-11-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Mesalamine - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-11-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Mesalamine - Padagis Israel Pharmaceuticals Ltd | Padagis Israel Pharmaceuticals Ltd | 2024-08-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Mesalamine - Perrigo New York Inc | Perrigo New York Inc | 2019-08-15 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 45802-098-46 | Mesalamine | 60 mL in 1 BOTTLE | ENEMA | 420 mL | 4 g in 60mL | 14 |
| 45802-923-41 | Mesalamine | 1 in 1 CARTON | KIT | 1 | 14 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 45802-923-41 | EA - Each | 45802-923 | ff56bce9-918f-4737-9443-505a0c3cc292 | 1 | 2012-07-24 |
| 45802-923-49 | EA - Each | 45802-923 | 730d663e-9f62-4882-a01f-5031f344fdba | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mesalamine | MESALAMINE | Sun Pharmaceutical Industries Inc. | c2f84490-70b8-4998-907d-a77e9f791de1 | 2024-08-27 | Warnings, Adverse reactions | 4Q81I59GXC |
| Mesalamine | MESALAMINE | Bryant Ranch Prepack | baa76dde-3c5b-4ff4-ba0c-f19660a796c1 | 2024-08-14 | Warnings, Adverse reactions | 4Q81I59GXC |
| Empathy | AETHUSA CYNAPIUM, AMBRA GRISEA, ARGEMONE MEXICANA, CANDIDA ALBICANS, CARLSBAD AQUA, CEREBRUM SUIS, COCCULUS INDICUS, COFFEA TOSTA, CROCUS SATIVUS, CYCLAMEN EUROPAEUM, MAGNESIA CARBONICA, NATRUM CARBONICUM, NUPHAR LUTEUM, NUX MOSCHATA, PHOSPHORUS, PLACENTA TOTALIS SUIS, ROSA DAMASCENA, SUCCINUM, VIOLA ODORATA | Deseret Biologicals, Inc. | a89067c1-ef12-49da-8fa6-e65ff664f497 | 2024-08-13 | Warnings | 059QF0KO0R |
| Mesalamine | MESALAMINE | Padagis Israel Pharmaceuticals Ltd | b2a5b110-7537-4ffc-bf0a-f0fe13379c9d | 2024-08-01 | Warnings, Adverse reactions | ANDA076751 45802-098-46 238151 |
| Mesalamine | MESALAMINE | Padagis Israel Pharmaceuticals Ltd | d50f2c37-5675-49f3-bdd4-3b16d333ed40 | 2024-08-01 | Warnings, Adverse reactions | ANDA076751 45802-098-46 45802-923-41 45802-923 238151 9e3de2df-02db-474c-9e16-47aeea34b2c5 d50f2c37-5675-49f3-bdd4-3b16d333ed40 |
| Mesalamine | MESALAMINE | Padagis Israel Pharmaceuticals Ltd | a4ddf68d-1502-4242-89aa-c96436bdcbf6 | 2024-08-01 | Warnings, Adverse reactions | ANDA076751 45802-098-51 45802-098-46 45802-098 238151 f416ded9-2018-4422-8cff-c6fc563a3772 a4ddf68d-1502-4242-89aa-c96436bdcbf6 4Q81I59GXC |
| Thompson Safety Eyewash | WATER | Thompson Safety | 1d0e96cf-245b-cfb7-e063-6294a90a4ced | 2024-07-12 | Warnings | 059QF0KO0R |
| Mesalamine | MESALAMINE | Ascend Laboratories, LLC | 43f69db3-81ac-4da4-a61f-fbba6299d9c2 | 2024-07-03 | Warnings, Adverse reactions | 4Q81I59GXC |
| Mesalamine | MESALAMINE | Teva Pharmaceuticals, Inc. | e3b84397-a5a5-40cf-8145-0584103d465f | 2024-06-28 | Warnings, Adverse reactions | 4Q81I59GXC |
| Mesalamine | MESALAMINE | Bryant Ranch Prepack | 06792d20-d7e9-4b66-a4cb-cd0cf1a2db25 | 2024-06-28 | Warnings, Adverse reactions | 4Q81I59GXC |
| Mesalamine | MESALAMINE | Rising Pharma Holdings, Inc. | de981df1-747a-480d-a866-e72332a1544d | 2024-06-14 | Warnings, Adverse reactions | 4Q81I59GXC |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Honeywell Safety Products USA, Inc. | ad42a7e3-84ea-390d-e053-2a95a90a3a32 | 2024-06-14 | Warnings | 059QF0KO0R |
| Eyes Alive Eye Wash | WATER | RIVIERA PHARMA INC | 081079f4-1c06-4054-b771-00fedaa666f6 | 2024-06-05 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Becton Dickinson and Company | 6e43c5a3-dad2-49ed-b500-964cb4563cc9 | 2024-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
| MESALAMINE | MESALAMINE | Bryant Ranch Prepack | 063ca661-1b5c-4941-a5b9-5dd0fa46b3d0 | 2024-05-29 | Warnings, Adverse reactions | 4Q81I59GXC |
| Mesalamine | MESALAMINE | Amneal Pharmaceuticals LLC | 00f77203-3615-47e8-ae25-6e1cf8a2a00a | 2024-05-23 | Warnings, Adverse reactions | 4Q81I59GXC |
| Sodium Phenylacetate and Sodium Benzoate | SODIUM PHENYLACETATE AND SODIUM BENZOATE | FOSUN PHARMA USA INC | cee1e9a2-bbe5-2419-e053-2a95a90ac3ef | 2024-05-09 | Warnings, Adverse reactions | OJ245FE5EU |
| Enviroclenz | BERBERIS VULGARIS, CARDUUS MARIANUS, CHELIDONIUM MAJUS, GLYCYRRHIZA GLABRA, LAPPA MAJOR, RHAMNUS FRANGULA, STILLINGIA SYLVATICA, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, GERMANIUM SESQUIOXIDE, PHYTOLACCA DECANDRA, ACETONE, AMMONIUM MURIATICUM, BENZINUM, PROPYLENE GLYCOL, SODIUM LAURYL SULFATE, SODIUM TRIPOLYPHOSPHATE, TEREBINTHINA, METHANOL, CHLORINUM, IRIDIUM METALLICUM, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM | Deseret Biologicals, Inc. | 92816bbe-96d6-45fc-9929-d3e6df394a33 | 2024-05-02 | Warnings | 6DC9Q167V3 |
| Mesalamine | MESALAMINE | Bryant Ranch Prepack | c9b1ef9d-1d06-48e7-87d2-7985b99124a6 | 2024-05-01 | Warnings, Adverse reactions | 238151 4Q81I59GXC |
| mesalamine | MESALAMINE | Golden State Medical Supply, Inc. | 170657d1-1f32-f036-e063-6294a90a4ed4 | 2024-04-26 | Warnings, Adverse reactions | 4Q81I59GXC |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.